Clinical trial · Interventional
Hemostatic Powder Versus Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions
Randomized Controlled Trial of Hemostatic Powder Versus Optimal Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions
NCT02820077CI-TRIAL-00046860terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Global recall of Hemospray
Summary
Brief summary (as posted)
This study evaluates the efficacy of the endoscopic hemostatic powder for the treatment of bleeding from malignant lesions of the upper GI tract. Half of participants will receive hemostatic powder and half will be submitted to standard treatment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastrointestinal Hemorrhage | — | UNRESOLVED | — |
| Gastrointestinal Neoplasms | Digestive System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hemospray (Endoscopic treatment with hemostatic powder) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Hemospray
- description
- Patients treated with hemostatic powder
- interventionNames
- Device: Hemospray (Endoscopic treatment with hemostatic powder)
- type
- NO_INTERVENTION
- label
- Clinical support
- description
- Patients treated with optimal clinical management, as it is been advised by the latest guidelines
Primary outcomes (2)
- measure
- rebleeding
- timeFrame
- until 30 days after endoscopy
- measure
- mortality
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Any kind of malignancy * Gastrointestinal bleeding in the last 48 hours * Referred to emergency endoscopy Exclusion Criteria: * under 18 years old * bleeding from non malignant lesions * previous endoscopic treatment with another method done in the last 48h
References
Publications (0)
Data not yet available
No reference posted for this study.